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Abstract 13 
The trimeric chaperone Skp sequesters outer membrane proteins (OMPs) within a 14 
hydrophobic cage, preventing their aggregation during transport across the periplasm in 15 
Gram negative bacteria. Here, we study the interaction between Escherichia coli Skp and 16 
five OMPs of varying size. Investigations of the kinetics of OMP folding reveal that greater 17 
Skp:OMP ratios are required to prevent the folding of 16-stranded OMPs compared with 18 
their 8-stranded counterparts. Ion mobility spectrometry-mass spectrometry (IMS-MS) data, 19 
computer modelling and molecular dynamics simulations provide evidence that 10- to 16-20 
stranded OMPs are encapsulated within an expanded Skp substrate cage. For OMPs which 21 
cannot be fully accommodated in the expanded cavity, sequestration is achieved by binding 22 
of an additional Skp trimer. The results suggest a new mechanism for Skp chaperone activity 23 
involving coordination of multiple copies of Skp to protect a single substrate from 24 
aggregation. 25 
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β-barrel outer membrane proteins (OMPs) perform numerous essential and diverse 26 
functions in the outer membrane (OM) of Gram negative bacteria. After synthesis in the 27 
cytoplasm, OMPs are translocated across the inner membrane, and then must traverse the 28 
periplasm before reaching the OM, where the β-barrel Assembly Machinery (BAM) complex 29 
folds and inserts them1-5.  While the periplasmic chaperones Skp and SurA are considered 30 
the major OMP chaperones in E. coli, a network of folding factors is involved in OMP 31 
assembly, including Trigger Factor and SecB in the cytoplasm, and FkpA and DegP in the 32 
periplasm1,6,7. Periplasmic chaperones act without an external energy source (unlike many of  33 
the Hsp chaperones8), as the periplasm is devoid of ATP5, and bind and release their 34 
substrates by mechanisms that are not well understood7. 35 
 36 
The holdase chaperone Skp protects OMPs against misfolding and aggregation during their 37 
transit between the inner and outer membranes9-11. Skp has broad substrate specificity12, 38 
with reported affinities for its substrates in the low nanomolar range13,14. Skp is a functional 39 
homotrimer (referred to herein as Skp) with a ‘jellyfish’-like architecture (Fig. 1a)10,11, 40 
consisting of three α-helical ‘legs’ that extend 60 Å away from the ‘body’ domain; a 9-41 
stranded β-barrel which mediates trimerisation10,11. The three subunits of Skp form a 42 
hydrophobic cavity inside which OMP clients are bound9,12,15,16, with previous studies 43 
suggesting a 1:1 stoichiometry for all Skp:OMP complexes13,17,18. These 1:1 stoichiometries 44 
have been proposed using tryptophan fluorescence (Skp complexes formed with tOmpA (19 45 
kDa)13, NalP (32 kDa)13, OmpG (33 kDa)13, OmpA (35 kDa)13,17 and BamA (89 kDa)13), by 46 
NMR (OmpX (16 kDa) and tOmpA (19 kDa)15) and by fluorescence correlation spectroscopy 47 
(OmpC (38 kDa)18). The Skp hydrophobic cavity has been estimated to be able to 48 
accommodate folded proteins of ~25 kDa10, but many OMPs known to interact with Skp are 49 
considerably larger (e.g. the 22-stranded BtuB and the 26-stranded LptD are 66 kDa and 87 50 
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kDa, respectively)12. This raises fundamental questions about the structural alterations that 51 
must occur for Skp to accommodate its larger substrates.  52 
 53 
To investigate the mechanism by which Skp sequesters OMPs of different sizes, we used 54 
kinetic studies of OMP folding complemented with electrospray ionization-ion mobility 55 
spectrometry-mass spectrometry (ESI-IMS-MS) analyses to examine the interactions of Skp 56 
with five diverse OMPs: 1) tOmpA, the 8-stranded transmembrane domain of OmpA19; 2) 57 
PagP, an 8-stranded acyl transferase enzyme20; 3) OmpT, a 10-stranded protease21; 4) 58 
OmpF, a 16-stranded trimeric porin22; and 5) tBamA, the 16-stranded transmembrane 59 
domain of the BamA OMP insertase23 (Fig. 1b-f, Supplementary Table 1). We find that the 60 
concentration of Skp required to prevent OMP insertion into diC11:0PC liposomes increases 61 
as the mass of client OMP increases, suggesting that the sequestration mechanism of Skp is 62 
altered for larger OMP clients.  ESI-IMS-MS and computer modelling were used to examine 63 
the conformations of Skp:OMP complexes and provided evidence that the core of Skp 64 
expands to accommodate the larger OMPs, with the largest clients requiring the formation of 65 
2:1 Skp:OMP assemblies to completely sequester the polypeptide chain. Combined, the 66 
results provide a new understanding of how Skp is able to bind, chaperone and release 67 
substrates that vary dramatically in size, with expansion of the binding cage and/or formation 68 
of multivalent complexes allowing the chaperone to adapt to the demands of its clients. 69 
 70 
  71 
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[The main text (currently ~4,600 words) is over our limit of 4,000 words for Articles. 72 
The Results are especially long, > 3,000 words; please trim Results to ~2,400 words] 73 
Results are now ~2,590 words 74 
Results 75 
Different Skp:OMP ratios are required to inhibit OMP folding 76 
To assess the effects of Skp on the folding and membrane insertion of OMPs of varied size, 77 
folding assays were performed by diluting unfolded protein stock solutions (in 8 M urea) 33-78 
fold into buffer containing ~100 nm diameter synthetic diC11:0PC liposomes. The increase in 79 
tryptophan fluorescence associated with folding was then measured as a function of time. 80 
Maintaining a low protein concentration (0.4 μM) and a high lipid:protein ratio (3200:1) 81 
enables folding to be monitored in a low final concentration of urea (0.24 M) without 82 
interference from aggregation. This approach enables real time measurements of folding 83 
that are complementary to SDS-PAGE based studies which have been used to provide 84 
information about the fraction of folded (SDS-resistant) protein present at a particular time24-85 
26. 86 
 87 
To verify that the OMPs selected for study are able to fold into diC11:0PC liposomes and/or 88 
interact with Skp under the experimental conditions selected, fluorescence emission spectra 89 
of each OMP were measured in 8 M or 0.24 M urea in the absence of liposomes (in the latter 90 
case with and without a two-fold molar excess of Skp). These spectra were then compared 91 
with those of membrane inserted (folded) OMP obtained at the end point of the folding 92 
reaction (Fig. 2a-d). Spectra of tOmpA, PagP, OmpF and tBamA folded into liposomes show 93 
a characteristic blue-shift in λmax and increase in fluorescence intensity compared with 94 
spectra of the unfolded proteins in 8 M urea, indicating that a substantial fraction of all four 95 
OMPs fold successfully into the liposomes employed. In the presence of Skp, the spectra of 96 
tOmpA, OmpF and tBamA show decreases in λmax and/or intensity compared with spectra of 97 
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these OMPs in buffer alone, demonstrating that these unfolded OMPs interact with Skp. For 98 
PagP no change in fluorescence is observed in the presence of Skp, although these proteins 99 
do interact, as shown in previous work27. 100 
 101 
The effect of Skp on OMP folding kinetics was next investigated. In the absence of Skp, the 102 
OMPs fold with either single or double exponential kinetics (Fig. 2a-d), allowing extraction of 103 
the folding rate constants (k1 and k2) (Fig. 2a-d, Supplementary Table 2). To verify that the 104 
transients obtained reflect membrane insertion and folding, assays were performed in the 105 
absence of lipids (Supplementary Fig. 1). A folding transient is observed only for OmpT in 106 
the absence of lipid (Supplementary Fig. 1e), presumably reflecting folding of the large 107 
extracellular region of OmpT which contains three tryptophan residues (Supplementary Fig. 108 
1f). For all other OMPs, no change in fluorescence was observed over time in the absence 109 
of lipid, indicating the formation of a stable soluble form, as previously reported13,27.  The 110 
folding kinetics of OMPs that had been pre-incubated with Skp at molar ratios ranging from 111 
1:1 to 4:1 (chaperone:client) (where Skp concentrations are in trimer equivalents, see Online 112 
Methods) were then measured by adding the pre-formed complexes to diC11:0PC liposomes 113 
and monitoring OMP folding by fluorescence spectroscopy (Fig. 2a-d, Supplementary Fig. 114 
2). The results show that at a substrate concentration of 0.4 µM, a 2-fold molar excess of 115 
Skp is sufficient to prevent tOmpA and PagP folding into liposomes (Fig. 2a, b, 116 
Supplementary Fig. 2a, b). We have previously shown that while incubation of Skp with 117 
PagP at a 2:1 ratio prevents OMP folding over a 2 h timescale, overnight incubation with 118 
liposomes allows OMP release and folding to equivalent yields as in the absence of Skp27. 119 
For both of the 8-stranded OMPs tOmpA and PagP, a 1:1 Skp:OMP ratio retards folding, 120 
while a 2:1 ratio prevents folding over the timescale of the experiment. By contrast, pre-121 
incubation of OmpF and tBamA with a 2-fold excess of Skp decreases the folding rate, but 122 
does not prevent folding (Fig. 2c, d, Supplementary Fig. 2c, d).  However, pre-incubation 123 
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with a 4-fold excess of Skp inhibits folding of these larger proteins over the timescale of the 124 
experiment (Fig. 2c, d, Supplementary Fig. 2c, d). The results suggest, therefore, that 125 
complete sequestration of larger OMP barrels requires the binding of more than one copy of 126 
Skp.  127 
 128 
Stoichiometries of Skp:OMP assemblies studied by ESI-MS 129 
To gain insights into the architectures of Skp:OMP assemblies, we exploited ESI-MS 130 
coupled with IMS to analyze different Skp:OMP complexes within multicomponent mixtures. 131 
Skp assemblies with tOmpA, PagP, OmpT, OmpF and tBamA were prepared, and mass 132 
spectra acquired using instrumental conditions that allow non-covalent interactions to be 133 
retained in vacuo (termed non-covalent or “native” MS)28-30 (see Online Methods) (Fig. 3, 134 
Supplementary Fig. 3a-f, Supplementary Table 3). The results show that all five Skp:OMP 135 
assemblies are sufficiently stable to survive the ESI process and be transferred into the gas 136 
phase for analysis.  137 
 138 
Several reports have suggested that Skp binds unfolded OMPs ranging from 16-89 kDa (8-139 
16 β-strands in the native state) with a 1:1 stoichiometry13,15,17,18. By contrast, the mass 140 
spectra shown in Fig. 3 reveal that the stoichiometry of these assemblies is dependent on 141 
the size of the OMP client, consistent with the kinetic traces described above. Thus, tOmpA 142 
and PagP (8-stranded OMPs) bind only one Skp, whilst the larger OMPs, OmpT, OmpF and 143 
tBamA (10- and 16-stranded OMPs) bind up to two copies of Skp. Peaks corresponding to 144 
monomeric Skp subunits were also observed (m/z ~2000) (Fig. 3), indicating either that 145 
some dissociation of the assembly is occurring in-source, and/or reflecting the population of 146 
monomeric subunits in solution31,32. Interestingly, a 2:1 assembly is the predominant 147 
complex observed in the spectrum for the largest 16-stranded OMP studied, tBamA, despite 148 
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being formed by mixing Skp with tBamA at a 1:1 molar ratio (Fig. 3f). A 2:1 Skp:OMP 149 
assembly was also observed for full-length BamA (Supplementary Fig. 4a,b). To confirm 150 
that the Skp:OMP stoichiometry observed using ESI-MS reflects the stoichiometry in solution, 151 
we performed chemical cross-linking with bis(sulfosuccinimidyl)suberate (BS3), followed by 152 
SDS-PAGE analysis of Skp pre-incubated with full-length OmpA or full-length BamA. In the 153 
cross-linked Skp:OmpA samples, a 1:1 assembly was observed (Supplementary Fig. 5a-d) 154 
whereas in the Skp:BamA samples a band consistent with a complex with a 2:1 155 
stoichiometry (but no 1:1 Skp:BamA complex) was observed (Supplementary Fig. 5e-g). 156 
 157 
Insights into Skp:OMP complex structure from ESI-IMS-MS 158 
How Skp binds its OMP clients of larger size was next analyzed using ESI-IMS-MS. IMS 159 
measures the mobility of ions through an inert gas-filled chamber under the influence of a 160 
weak electric field, with the drift time (mobility) of an ion in this environment dependent on its 161 
mass, size and charge28,33. Here, we used travelling wave IMS-MS28,33, for which calibration 162 
of the measured drift time data can be performed to obtain rotationally averaged collision 163 
cross-sections (CCSs), to provide insight into the conformations of Skp and the Skp:OMP 164 
assemblies. IMS data were acquired for all of the assemblies studied (Fig. 4a-f, 165 
Supplementary Fig. 3a-f), and compared with known structures where available, or with 166 
models of the Skp:OMP complexes for which there are no high resolution structural data. 167 
 168 
Fig. 4a-f displays the CCS distributions of the observed ions originating from Skp and 1:1 169 
Skp:OMP complexes, normalized to spectral intensity (a representative dataset is shown 170 
from three independent experiments). The modal CCSs are also plotted as a function of 171 
charge state in Fig. 4g (Supplementary Table 4). Interestingly, the CCSs of the Skp ions 172 
(Fig. 4g) are smaller than expected based on the published Skp crystal structure (the modal 173 
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CCS at the lowest observed charge state, which is least affected by Coulombic repulsion34, 174 
was 37.9 nm2, approximately 25 % lower than the expected value of 45.7 nm2 derived from 175 
the crystal structure (Fig. 4g)). Molecular dynamics simulations (Supplementary Fig. 6, 176 
Supplementary Data Sets 1 and 2) revealed that the assembly collapses in the gas phase, 177 
resulting in a structure with CCS of 37.3 ± 1.9 nm2 (Fig. 4g).  178 
 179 
Binding of Skp to the 8-stranded tOmpA and PagP (Fig. 4g) results in ions with increased 180 
CCS compared with Skp alone. The CCSs of the ions observed (45.6 nm2 and 45.8 nm2 for 181 
Skp:tOmpA and Skp:PagP, respectively, at the lowest observed charge state) compare 182 
favorably with the CCS predicted from the crystal structure of Skp alone (45.7 nm2), 183 
supporting the notion that these assemblies are specific complexes in which the OMP is 184 
located within the central Skp cavity, preventing collapse of the chaperone in the gas 185 
phase15,16. Consistent with this, the Skp:OMP complexes sample a narrower conformational 186 
ensemble compared with Skp alone, measured by the width at half height of the mobility 187 
peaks observed (Fig. 4a-c). Complexation with tOmpA and PagP thus packs the 188 
hydrophobic cavity of Skp resulting in a narrower conformational ensemble, consistent with 189 
previous data15. 190 
 191 
Interestingly, the 1:1 Skp:OMP assemblies of the larger OMPs studied (OmpT, OmpF and 192 
tBamA) (Fig. 4g) have increased CCSs (51.4-54.2 nm2) compared with the Skp:tOmpA and  193 
Skp:PagP assemblies (~46 nm2). These data, together with mismatch between the volume 194 
of Skp’s cavity and the volume likely to be occupied by larger OMP clients in the ‘fluid 195 
globule’ state15, suggest that the central cavity expands in size to encapsulate these species, 196 
consistent with recent SANS data35. However, the kinetic data (Fig. 2c,d) indicate that Skp 197 
expansion is insufficient to fully sequester these larger OMPs in a 1:1 complex. 198 
9 
 
 199 
Plotting the increase in CCS as a function of molecular weight for Skp and all complexes 200 
(Fig. 4h), including 2:1 Skp:OMP assemblies (Supplementary Fig. 3g), reveals that the 201 
data fit to a globular model, irrespective of client size. The complexes exhibit an effective gas 202 
phase density of 0.33 Da.Å-3, similar to values reported for other protein complexes33, and 203 
consistent with recent calculations of the CCSs of globular proteins in the PDB 36. 204 
 205 
Modelling of larger OMPs in complex with two copies of Skp 206 
Models for the architecture of Skp in complex with OmpT, tBamA or OmpF were next 207 
generated to determine how Skp and a partially folded OMP may interact. Four different 208 
models were constructed. As a starting point, encapsulated tOmpA was modelled as a 209 
sphere with a radius of 20 Å (Fig. 5a) which has a volume of 33,500 Å3, consistent with 210 
previous estimates10,15. We assumed that the amino acid density for non-native OMPs bound 211 
to Skp is independent of the mass of the OMP studied, consistent with the MS data 212 
presented above. Therefore, to model a 16-stranded OMP, we assumed a spherical volume 213 
of ~67,000 Å3 giving a radius of ~25 Å, and generated a Skp model with its three subunits 214 
surrounding a sphere of this size (Fig. 5b). The theoretical CCS of the resulting structure 215 
(50.4 nm2) (Fig. 4g) is in good agreement with the measured CCS values for 1ː1 SkpːOmpT, 216 
Skp:OmpF and Skp:tBamA complexes (51.4, 51.8 and 54.2 nm2, respectively) (Fig. 4g, 217 
Supplementary Table 4). The results suggest, therefore, that 1:1 Skp:OMP complexes with 218 
larger OMPs, involve an expanded Skp cavity. 219 
 220 
Next, we generated models of the 2:1 Skp:OMP complexes, theorizing that Skp could 221 
arrange in a side-by-side configuration, in either a parallel or antiparallel arrangement (Fig. 222 
5c,d), with the OMP represented by a capsule. The theoretical CCSs of these assemblies 223 
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were determined to be 79.1 and 78.2 nm2, respectively (Fig. 4g). Alternatively, we 224 
considered a model in which the OMP substrate (represented by a sphere with a radius of 225 
~25 Å) may be encapsulated by two interlocked copies of Skp (Fig. 5e), which results in a 226 
complex with a theoretical CCS of 73.5 nm2 (Fig. 4g). All three values are in good 227 
agreement with the measured CCS values for 2:1 Skp:OmpT, Skp:OmpF and Skp:tBamA 228 
complexes (71.7, 71.2 and 72.8 nm2, respectively) (Fig. 4g, Supplementary Table 4).  229 
 230 
Molecular dynamics simulations to model Skp:OMP complexes  231 
To model the Skp:OMP complexes further and aid their visualization, we performed a series 232 
of molecular dynamics simulations.  A simulation of apo-Skp in explicit solvent over 100 ns 233 
demonstrated that the individual subunits are highly dynamic and flexible. Each subunit 234 
undergoes a transition to an ‘open’ state, in which subunit helices splay from the central axis, 235 
resulting in an expanded central cavity, consistent with previous MD studies18,35  236 
(Supplementary Fig. 7a-c, Supplementary Data Sets 1 and 3, Supplementary Video 1). 237 
The average radius of gyration (Rg) of Skp from the simulation (31.5 Å) is in good agreement 238 
with published SANS data (~33 Å)35.  This Rg is ~10 % higher than that predicted from the 239 
crystal structure, indicating that dynamic motions of the Skp subunits observed in the 240 
simulation likely reflect those in solution. In the two Skp crystal structures solved to date10,11, 241 
the lower section of one of the subunits is unresolved, indicating flexibility, and the angles 242 
with which the Skp subunits extend away from the ‘body’ domain are different for each of the 243 
subunits in the two structures10,11. The subunits in the crystal structure of the 244 
heterohexameric eukaryotic chaperone prefoldin (Fig. 5f) also make different angles with 245 
respect to the multimerisation domain, which has also been suggested to indicate 246 
conformational flexibility that may be functionally relevant37. 247 
 248 
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Next, we generated models of tOmpA (8-stranded) and tBamA (16-stranded) alone in an 249 
unfolded, extended conformation, and simulated their behavior in solvent (mimicking the 250 
situation in which OMPs are diluted from 8 M urea). In each case, the OMPs collapse rapidly 251 
to an approximately globular form (Supplementary Fig. 7d,e, Supplementary Video 2). A 252 
model of the 1:1 Skp:tOmpA complex was then generated by placing the collapsed tOmpA 253 
structure within the cavity of Skp in an ‘open’ conformation from the simulation of apo-Skp 254 
(Supplementary Fig. 7b) and relaxing the resulting structure in vacuo. In the simulation, the 255 
subunits of Skp collapse rapidly around the tOmpA substrate resulting in a structure with a 256 
CCS value (43.7 ± 1.2 nm2) in excellent agreement with that measured by ESI-IMS-MS (45.6 257 
± 0.1 nm2), suggesting that, at least in the gas phase, Skp “clamps” around the substrate  258 
(Fig. 6a,b, Supplementary Video 3). A model for the gas-phase 2:1 Skp:tBamA complex 259 
was created by placing the collapsed tBamA structure in the hydrophobic cavity formed by 260 
two copies of Skp in their ‘open’ conformations. A side-by-side parallel orientation (Fig. 6c) 261 
was chosen based on the striking resemblance of this model to the structure the eukaryotic 262 
prefoldin chaperone37 (Fig. 5f). The size of the collapsed tBamA model clearly exceeds the 263 
maximal dimensions of the cavity of a single Skp observed in an ‘open’ conformation (Fig. 264 
6c). Simulation of the 2:1 Skp:tBamA complex in vacuo showed that the Skp subunits also 265 
rapidly “clamp” around the tBamA substrate creating a complex with a CCS value (74.4 ± 1.4 266 
nm2) again in good agreement with the IMS data (72.8 ± 0.2 nm2) (Fig. 6d, Supplementary 267 
Video 4). Thus, the CCS data obtained from both experiment and simulation 268 
(Supplementary Table 5) are consistent with a model in which multivalent Skp binding is 269 
necessary to sequester OMPs that exceed the dimensions of the Skp cavity. 270 
 271 
To provide evidence that a similar “clamping” motion of Skp around its OMP substrates 272 
could occur in solution, we performed analogous MD simulations of Skp:tOmpA and 2:1 273 
Skp:tBamA complexes in explicit solvent. In these simulations Skp subunits are also 274 
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observed wrapping around their OMP substrates (Fig. 7a,b, Supplementary Videos 5,6), 275 
with ‘clamping’ movements similar to those observed in the gas-phase simulations (Fig. 6). 276 
The complexes formed are stable over 100 ns (Fig. 7c,d) and have larger calculated CCS 277 
values (56.5 ± 0.3 nm2 and 101.2 ± 6.0 nm2 for Skp:tOmpA and 2:1 Skp:tBamA, respectively) 278 
than those following gas-phase simulation (43.7 ± 1.2 nm2 and 74.4 ± 1.4 nm2 for Skp-279 
tOmpA and 2:1 Skp-tBamA, respectively). These data are consistent with a model in which 280 
the subunits of Skp are dynamic, resulting in expansion of the hydrophobic cavity that allows 281 
entry of substrates of varying sizes, prior to the Skp subunits ‘wrapping’ around the 282 
sequestered client to protect it from aggregation until folding into the bilayer can take place. 283 
  284 
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Discussion 285 
Major advances in the understanding of the cascade of molecular chaperones and folding 286 
catalysts involved in OMP biogenesis have been made in recent years, yet the molecular 287 
details of how OMPs are bound by molecular chaperones, transported across the periplasm 288 
and assembled into the outer membrane, without using the energy of ATP binding/hydrolysis, 289 
remain unclear1,7,23. Here, we have provided new insights into how Skp is able to chaperone 290 
its broad array of OMP clients, including substrates which are too large to be accommodated 291 
within its hydrophobic cavity. We have shown that Skp utilizes subunit dynamics to expand 292 
the size of its client binding cavity and have demonstrated that Skp can function as a 293 
multivalent chaperone in order to sequester and prevent aggregation of its larger OMP 294 
clients. Further, we have used ESI-IMS-MS to gain structural insight into the 1:1 and 2:1 295 
Skp:OMP complexes we have identified. Using kinetic refolding and ESI-IMS-MS data, 296 
combined with MD simulations, we present models consistent with the experimental results 297 
in which Skp sequesters larger OMPs by binding in a multivalent arrangement (side-by-side 298 
parallel or anti-parallel, and/or via an interlocking structure) (Fig. 5c-e). The parallel side-by-299 
side model (Fig. 5c) bears a striking resemblance to the structure of the non-homologous 300 
chaperone prefoldin (Fig. 5f)37.  The precise orientation(s) of Skp molecules in these 301 
multivalent complexes will require more information to resolve, for example using cross-302 
linking experiments followed by MS/MS. Nonetheless, the biochemical, MS and MD results 303 
presented indicate that the ability of Skp to chaperone OMPs ranging from 35-43 kDa in size 304 
requires both subunit dynamics and its ability to function as a multivalent chaperone. 305 
 306 
 307 
 308 
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Skp has been shown in vivo to interact with much larger substrates than those investigated 309 
here (19-43 kDa), including BtuB (66 kDa), FhuA (79 kDa) and LptD (87 kDa) which form β-310 
barrels composed of 22, 22, and 26 β-strands, respectively12,38. It is likely these proteins also 311 
form multivalent complexes with Skp and indeed recent data on the interaction between Skp 312 
and FhuA is consistent with a greater than 1:1 Skp:OMP stoichiometry39.   313 
 314 
The results presented have implications for our understanding of how OMPs are chaperoned 315 
by Skp in the periplasm, including the mechanisms of substrate binding and release. Our 316 
atomistic MD trajectories of apo-Skp show that it exists in a wide range of open 317 
conformations with large differences in the area of the cavity entrance formed between the 318 
tips of its three subunits. Such conformational flexibility has been implicated in the 319 
mechanisms of other ATP-independent chaperones40,41. We propose that in rescuing 320 
aggregation-prone proteins6 Skp could be thought of as analogous to a pair of ‘calipers’, 321 
sampling open conformations prior to capture of its client, allowing it to adjust the volume of 322 
its central cavity.  In this model once the substrate has entered the Skp cavity, the Skp 323 
subunits ‘clamp down’ to protect the exposed hydrophobic surfaces of the protein, in a 324 
mechanism similar to those of other chaperones such as Trigger Factor or Hsp9042. For 325 
substrates which are too large to be accommodated within the Skp substrate cavity, 326 
additional copies of Skp recognize and engulf sections of the substrate not already 327 
encapsulated. In vivo cross-linking evidence suggests that Skp can interact with OMPs as 328 
they emerge from the SecYEG translocon43. Thus it is possible that during translocation of 329 
larger OMPs, the substrate is fed directly into the cavity of Skp and the chaperone’s 330 
maximum binding capacity would then be reached before the complete polypeptide chain is 331 
translocated. Subsequent polypeptide chain emerging from the translocon could then be 332 
bound by a second or more Skp(s), ensuring sequestration of the entire polypeptide 333 
sequence so that periplasmic aggregation is prevented. 334 
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 335 
Recent equilibrium sedimentation experiments of Skp in the absence of substrate have 336 
demonstrated a dynamic equilibrium between folded subunit monomers and trimers at 337 
physiological concentrations32. Therefore, a possible alternative in vivo pathway to Skp-OMP 338 
complex formation may involve sequential binding of monomer subunits to OMP substrates, 339 
with Skp trimerization linked to (and indeed driven by) substrate binding. Sandlin et al. raise 340 
the possibility that more diverse species of Skp could form around an unfolded OMP32. 341 
However, for the complexes studied here only Skp-OMP complexes containing monomeric 342 
Skp subunits in multiples of three are observed (Fig. 3), suggesting either that the trimeric 343 
unit is the OMP binding species, or that complexes of other composition are unstable in the 344 
gas-phase. 345 
 346 
It has been proposed that transient exposure of the C-terminal OMP targeting sequence (β-347 
signal)44,45, and its recognition by the BAM complex46, triggers substrate release from Skp15. 348 
The space between Skp subunits (∼25 Å in the crystal stucture10) and/or the inherent 349 
dynamics of the complex may facilitate the transient solvent-exposure of regions of the OMP 350 
substrate, permitting β-signal recognition. Consistent with this, the presence of BamA in 351 
liposomes relieves the folding inhibition of OmpA by Skp in vitro47.  It is interesting to note 352 
that in all 2:1 Skp:OMP models proposed here there remains a substantial distance (> 20 Å) 353 
between the Skp subunits which would permit exposure of sections of the substrate 354 
polypeptide required for BAM signalling and/or membrane insertion. The release of the OMP 355 
from Skp is likely to be driven by the increased thermodynamic stability of the folded OMP 356 
relative to the chaperone-bound state48, and for OMPs that are bound to more than one Skp, 357 
it is possible that individual copies of Skp are released sequentially in a process driven by 358 
the free energy of OMP folding. 359 
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 360 
Chaperones utilize two general strategies to protect substrates from misfolding and 361 
aggregation.  In the first, substrates are chaperoned by sequential binding and release of 362 
exposed hydrophobic surfaces along an extended polypeptide chain. This ‘beads on a string’ 363 
model is typified by chaperones such as the Hsp70s and Trigger Factor8,49. Alternatively, 364 
aberrant interactions may be prevented by sequestration of the substrate from the cellular 365 
environment within an enclosed space, as is the case for the ‘cage-like’ chaperonins such as 366 
GroEL/ES and TriC8,49. The data presented here suggest that Skp operates with a ‘hybrid’ 367 
mechanism, employing both of these strategies to bind and encapsulate its OMP clients, 368 
thereby preventing their aggregation and facilitating their delivery to the OM wherein folding 369 
can successfully occur.  370 
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Figure legends for main text 533 
 534 
Figure 1: Three-dimensional structures of Skp and the OMPs used in this study (a) 535 
Skp (PDB 1U2M11), (b) tOmpA (PDB:1G9050), (c) PagP (PDB:1THQ51), (d) OmpT 536 
(PDB:1I7821), (e) OmpF (PDB:2ZFG22), and (f) tBamA (PDB 4N7552).  All structures are to 537 
scale. OmpF is a functional trimer; for clarity only one subunit is colored and the other two 538 
are shown in grey. Residues missing from chains B and C in the Skp crystal structure were 539 
modelled from chain A (green). In (b)-(f) the OM is represented in pale green, and 540 
approximate positions of OMPs within the membrane are judged by the position of residues 541 
in the ‘aromatic girdles’ at either side of the membrane53.     542 
 543 
Figure 2: Different Skp:OMP ratios are required to sequester OMPs and inhibit folding. 544 
Folding data for (a) tOmpA, (b) PagP, (c) OmpF, and (d) tBamA. Fluorescence emission 545 
spectra (left) of OMPs folded in diC11:0PC liposomes (red lines), unfolded in 8M urea (grey 546 
lines), in buffer alone in the absence of lipids (purple lines), and in the presence of a 2-fold 547 
molar excess of Skp (cyan lines). Final OMP concentrations were 0.4 µM, with a molar 548 
lipid:protein ratio of 3200ː1 (in folded samples), in 0.24 M urea, 50 mM glycine-NaOH, pH 549 
9.5, at 25 ºC. Kinetic traces (middle) for the folding of OMP alone into diC11:0PC liposomes 550 
(red lines), and in the presence of Skp at a 1:1 molar ratio (trimer equivalents, see Methods) 551 
(tOmpA and PagP, green lines, parts (a) and (b)), a 2:1 molar ratio (cyan lines, parts (a)–(d)), 552 
a 4:1 molar ratio (OmpF and tBamA, orange lines, parts (c) and (d)), or in the absence of 553 
lipids (purple lines).  Single or double exponential fits to the data (see Supplementary Table 554 
2) are shown as dotted lines. Rate constants for OMP folding in the absence or presence of 555 
Skp at the OMP:Skp ratio indicated (right). Where the data were best described by a double 556 
exponential fit, the rate constants for the second, slower, phase are not shown (see 557 
Supplementary Table 2 for full details). A star indicates a Skp:OMP ratio where folding did 558 
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not occur on the timescale of these experiments. Data are shown as mean ± standard 559 
deviation of three independent experiments using three separate liposome batches. 560 
 561 
Figure 3: Skp:OMP complexes have different stoichiometries. ESI mass spectra of (a) 562 
Skp (5 μM) and Skp pre-incubated in the presence of 5 μM (b) tOmpA, (c) PagP, (d) OmpT, 563 
(e) OmpF and (f) tBamA. Spectra are annotated with red circles (Skp), green squares (1:1 564 
Skp:OMP) and blue triangles (2:1 Skp:OMP). The most abundant charge state is labelled for 565 
each distribution. Observed masses for the complexes are summarized in Supplementary 566 
Table 3. Complementary IMS data are displayed in Supplementary Fig. 3.  567 
 568 
Figure 4: Collision cross-section distributions of Skp and Skp:OMP complexes. CCS 569 
distributions (peak heights normalized to MS peak intensity) of (a) Skp and 1:1 Skp:OMP 570 
complexes with (b) tOmpA, (c) PagP, (d) OmpT, (e) OmpF and (f) tBamA. The width at half 571 
height (normalized for spectral intensity) for each distribution is indicated (dashed lines), as 572 
well as the charge states which are represented by each CCS distribution. (g) Plot of 573 
observed CCSs of the assemblies as a function of charge state (mean of three replicates 574 
shown, note that standard deviation values are smaller than the symbol size used): Skp, 575 
black squares; 1:1 Skp:tOmpA, red circles; 1:1 Skp:PagP, green circles; 1:1 Skp:OmpT, 576 
orange circles; 1:1 Skp:OmpF, blue circles; 1:1 Skp:tBamA, purple circles; 2:1 Skp:OmpT, 577 
orange open squares; 2:1 Skp:OmpF, blue open squares; 2:1 Skp:tBamA, purple open 578 
squares. Dashed lines indicate CCSs estimated from (i) the collapsed structure of Skp from 579 
the MD simulation (black) (Supplementary Fig. 7e), (ii) the crystal structure of Skp (red), (iii) 580 
a model 1:1 Skp:OMP complex with an expanded central cavity (orange), (iv) a model 2:1 581 
Skp:OMP complex comprising two interlocking Skp molecules (green) and (v) a model 582 
(Skp)2:OMP complex arranged in a side-by-side fashion (pink)  (Fig. 5). (h) Plot of the lowest 583 
measured CCS of each assembly as a function of molecular weight (symbols as in (g)). The 584 
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line represents the expected CCSs for globular proteins with an amino acid density of 0.33 585 
Da.Å-3. 586 
 587 
Figure 5: Possible architectures of Skp:OMP complexes. Side (left) and bottom (right) 588 
view surface representations of models of (a) Skp (yellow) (based on the published crystal 589 
structure (PDB: 1U2M10) with missing residues modelled by molecular replacement), bound 590 
to an 8-stranded OMP represented by a grey sphere of radius 20 Å, (b) Skp with an 591 
expanded central cavity surrounding a 16-stranded OMP represented by a grey sphere of 592 
radius 25 Å, (c,d) 2:1 Skp:OMP structures (Skp colored in yellow and green) arranged side-593 
by-side in a (c) parallel or (d) antiparallel arrangement, with the 16-stranded OMP substrate 594 
represented by a grey capsule with cylinder height of 37 Å and cap radii of 20 Å, (e) 2:1 595 
Skp:OMP complex with an interlocked architecture with the 16-stranded OMP represented 596 
by a grey sphere of radius 25 Å,  and (f) the hexameric eukaryotic chaperone prefoldin (PDB: 597 
1FXK37), with chains A, B and C of the crystal structure shown in green, cyan and yellow, 598 
respectively. 599 
 600 
Figure 6: In vacuo molecular dynamics simulations of 1:1 and 2:1 Skp-OMP 601 
complexes. (a) Starting model of a 1:1 Skp:tOmpA complex used for MD simulations 602 
(Supplementary Data Set 4), and (b) the structure obtained after 10 ns of in vacuo 603 
simulation (Supplementary Data Set 5).  (c) Starting model of a 2:1 Skp:tBamA complex 604 
used for MD simulations, with the two copies of Skp arranged in a side-by-side parallel 605 
orientation (Fig. 5c) (Supplementary Data Set 6), and (d) the structure obtained after 10 ns 606 
of in vacuo simulation (Supplementary Data Set 7). Views from the side (top row) and 607 
bottom (bottom row) are shown. Skp (green/blue) is shown in cartoon representation. OMPs 608 
(yellow) are shown in surface representation. Representative structures are shown from 609 
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three independent MD simulations, and CCS values in the text are the mean ± standard 610 
deviation of three MD simulations. 611 
 612 
Figure 7: Molecular dynamics simulations of 1:1 and 2:1 Skp:OMP complexes in 613 
explicit solvent. (a) Starting model of a 1:1 Skp:tOmpA complex used for MD simulations 614 
(left) (Supplementary Data Set 4) and the structure obtained after 100 ns of simulation in 615 
explicit solvent (right) (Supplementary Data Set 8). (b) Starting model of a 2:1 Skp:tBamA 616 
complex used for MD simulations (left) (Supplementary Data Set 6), with the two copies of 617 
Skp arranged in a side-by-side parallel orientation (Fig. 5c), and the structure obtained after 618 
100 ns of simulation in explicit solvent (right) (Supplementary Data Set 9). (c,d) Backbone 619 
RMSDs calculated for the 100 ns simulations of (c) 1:1 Skp:tOmpA, and (d) 2:1 Skp:tBamA 620 
in explicit solvent, demonstrating that the complexes are stable over this timescale. 621 
Representative structures are shown from three independent MD simulations, and CCS 622 
values in the text are the mean ± standard deviation of three MD simulations.   623 
  624 
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Online Methods 625 
Cloning of OmpF, tBamA and OmpT 626 
A codon optimized synthetic gene (Eurofins, Germany) of the mature sequence of OmpF 627 
(residues 23-362) was cloned into pET11a  (Novagen, UK) between the NdeI (5′) and 628 
BamHI (3′) restriction sites. To create the tBamA construct, residues 425-810 of BamA were 629 
amplified by PCR, using plasmid BamAB-pETDUET-1 (kindly donated by Dr Susan 630 
Buchanan (NIH, USA)) as the template, and the resultant product then ligated into pET11a 631 
as described above. The OmpT mature sequence (residues 21-217) was amplified by PCR 632 
from E. coli XL1-blue cells to include an N-terminal 6xHis-tag and TEV protease cleavage 633 
site (MH6ENLYFQG-OmpT), and subsequently cloned into the pET11a vector as described 634 
above. The plasmids for tOmpA, PagP, OmpA and BamA encoding the mature OMP 635 
sequences were kindly provided by Dr Karen Fleming (John Hopkins University, USA)25. 636 
 637 
Expression and purification of PagP, tOmpA, OmpF, tBamA, OmpA and BamA 638 
The relevant plasmid was transformed  into BL21[DE3] cells (Stratagene, UK) and the 639 
appropriate OMP was expressed and purified as previously described27. Protein 640 
concentrations were determined spectrophotometrically using molar extinction coefficients at 641 
280 nm of 82,390, 46,870, 54,210, 101,315, 52,955 and 140,040 M-1 cm-1 for PagP, tOmpA, 642 
OmpF, tBamA, OmpA and BamA, respectively. 643 
 644 
Expression and purification of OmpT 645 
Expression and purification for OmpT was carried out as previously described54. Protein 646 
concentration was determined spectrophotometrically using a molar extinction coefficient at 647 
280 nm of 79,760 M-1 cm-1. 648 
 649 
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Expression and purification of Skp 650 
The pET21b plasmid, containing the full-length Skp gene, including the N-terminal signal 651 
sequence, was transformed into BL21[DE3] cells (Stratagene, UK).  Cells were grown in LB 652 
medium containing 100 µg/mL carbenicillin at 27 °C with shaking (200 rpm) until the culture 653 
reached an OD600 of ~0.6 (after ~6 h). Cultures were induced with 25 µM IPTG, expressed 654 
overnight, and harvested by continuous centrifugation at 15000 rpm (Heraeus Contifuge, 655 
Rotor 8575, Thermo Fisher Scientific, UK).  The cell pellet was resuspended in 50 mM Tris-656 
HCl, 5 mM EDTA, 50 mM NaCl, pH 7.5 at 4 °C with gentle agitation for ~48 h. 1 mg/mL 657 
polymyxin B sulphate was added to the resuspended cells, and then incubated for 1 h at 658 
4 °C with gentle agitation. Spheroplasts were sedimented by centrifugation (12 000 g, 20 659 
min 4 °C) and the supernatant dialyzed against 20 mM Tris-HCl, 100 mM NaCl, pH 8.0 660 
(Buffer A) overnight at 4 °C. The periplasmic extract was filtered (0.4 µm syringe filter, 661 
Sartorius, UK) and loaded onto a HiTrapQ (5 mL) anion exchange column (GE Healthcare, 662 
UK).  The flow through from this column was loaded onto a HiTrap SP (5 mL) cation 663 
exchange column (GE Healthcare, UK) equilibrated with Buffer A.  The column was washed 664 
with 5 column volumes of Buffer A and eluted with a gradient (0-100 %) of 20 mM Tris-HCl, 665 
750 mM NaCl, pH 8.0 (Buffer B). Peak fractions were dialysed against 20 mM Tris-HCl, pH 666 
8.0 and concentrated to ~50 µM (trimer) using Vivaspin 20 (5 kDa MWCO) concentrators 667 
(Sartorius, UK). Aliquots were snap-frozen in liquid nitrogen and stored at -80 °C. Protein 668 
concentrations were determined using a bicinchoninic acid (BCA) assay (Thermo Fisher 669 
Scientific, UK), according to the manufacturer’s instructions. 670 
 671 
Expression and purification of His-tagged Skp 672 
His-tagged Skp was expressed and purified using a protocol adapted from Burmann et al.15. 673 
The pET28b plasmid, containing the Skp gene with an N-terminal 6xHis-tag and thrombin 674 
cleavage site, was transformed into BL21[DE3]pLysS cells (Stratagene, UK). Cells were 675 
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grown in LB medium containing 30 µg/mL kanamycin at 37 °C with shaking (200 rpm) until 676 
the culture reached an OD600 of ~0.6. The temperature was then lowered to 20 °C and 677 
expression induced with 0.4 mM IPTG. Following overnight expression (~18 h) cells were 678 
harvested by centrifugation, resuspended in 25 mM Tris-HCl, pH 7.2, 150 mM NaCl, 20 mM 679 
imidazole, containing a cocktail of EDTA-free protease inhibitors (Roche), and lysed using a 680 
cell disrupter (Constant Cell Disruption Systems, UK).  Following centrifugation to remove 681 
cell debris (20 mins, 4 °C, 39000 g), the lysate was applied to 5 mL HisTrap columns (GE 682 
Healthcare) and washed with 25 mM Tris-HCl, pH 7.2, 150 mM NaCl, 20 mM imidazole.  683 
His-tagged Skp was denatured on-column with 25 mM Tris-HCl, 6 M Gdn-HCl, pH 7.2, and 684 
eluted with a 0-500 mM imidazole gradient over 50 mL in 25 mM Tris-HCl, 6 M Gdn-HCl, pH 685 
7.2. Fractions containing Skp were pooled and the protein refolded by dialysis against 25 686 
mM Tris-HCl, pH 7.2, 150 mM NaCl. Refolded His-tagged Skp was concentrated to ~50 µM 687 
(trimer) using Vivaspin 20 (5 kDa MWCO) concentrators (Sartorius, UK), aliquoted, snap-688 
frozen in liquid nitrogen and stored at -80 °C.  Protein concentrations were determined using 689 
a bicinchoninic acid (BCA) assay (Thermo Fisher Scientific, UK), according to the 690 
manufacturer’s instructions. 691 
 692 
Preparation of liposomes 693 
1,2-diundecanoyl-sn-glycero-3-phosphocholine (diC11:0PC) (DUPC) lipids were purchased 694 
from Avanti Polar Lipids (Alabama, USA).  DUPC was obtained as a powder, dissolved in a 695 
80:20 chloroform:methanol mixture at 25 mg/mL, and stored at -20 ºC until use. Appropriate 696 
volumes were transferred to glass test tubes and an even lipid film was created by drying 697 
with a gentle stream of nitrogen while being shaken moderately in a 42 ºC water bath. Lipid 698 
films were further dried in a vacuum desiccator for >3 h, followed by resuspension in 50 mM 699 
glycine-NaOH, pH 9.5 to a concentration of 40 mM. Resuspended lipids were vortexed 700 
briefly and allowed to stand for 30 min. After vortexing again, lipids were subjected to 5 701 
freeze-thaw cycles using liquid nitrogen. Large Unilamellar Vesicles (LUVs) (100 nm) were 702 
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prepared by extruding the lipid suspension 11 times through a 0.1 µm polycarbonate 703 
membrane (Nuclepore, New Jersey, USA) using a mini extruder (Avanti Polar Lipids, 704 
Alabama, USA).  Liposomes were stored at 4 ºC and used within 48 h of preparation. 705 
 706 
Kinetic folding assays 707 
Kinetic measurements were carried out using a Quantum Master Fluorimeter (Photon 708 
Technology International, UK) controlled by FelixGX software v4.3.  For each experiment, 709 
four separate samples were run in a four cell changer maintained at 25 ºC by a peltier-710 
controlled temperature unit. Tryptophan fluorescence of samples was excited at a 711 
wavelength of 295 nm, and fluorescence emission was monitored at 335 nm. 295 nm rather 712 
than 280 nm was chosen as the excitation wavelength as this minimizes the fluorescence 713 
intensity contribution from Skp, which contains tyrosine but no tryptophan residues. The 714 
excitation slit widths were set to 0.4-0.6 nm and the emission slit widths were set to 5 nm. 715 
The high emission:excitation slit width ratio was important to minimize photobleaching on the 716 
experimental time-scale. OMPs were buffer exchanged from 25 mM Tris-HCl, 6 M Gdn-HCl, 717 
pH 8.0 into 50 mM glycine-NaOH, 8 M urea, pH 9.5 using Zeba spin desalting columns 718 
(Thermo Scientific, UK) and diluted to 80 µM. OMP folding reactions in the absence of Skp 719 
were initiated by diluting OMPs manually from this 80 µM unfolded protein stock in 8 M urea 720 
to a final concentration of 0.4 µM protein and 0.24 M urea in the presence of 1.28 mM DUPC 721 
liposomes (a lipid:protein molar ratio (LPR) of 3200:1), in 50 mM glycine-NaOH, pH 9.5. 722 
Stable folding of Skp in 0.24 M urea was verified by CD (data not shown). The final volume 723 
for each sample was 500 µL.  For Skp-OMP experiments, OMPs were pre-incubated with 724 
Skp for approximately 1 min prior to addition of liposomes.  OMPs were diluted and mixed 725 
from an 80 µM stock in 8 M urea to a final concentration of 2.4 µM, in the presence the 726 
appropriate molar ratio of Skp, in 0.24 M urea, 50 mM glycine-NaOH, pH 9.5 (no lipids). This 727 
Skp-OMP stock was then further diluted 6x in presence of 1.28 mM DUPC in 0.24 M urea, 728 
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50 mM glycine-NaOH, pH 9.5 to begin the assay. The final volume for each sample was 540 729 
µL. At the concentrations of Skp utilized here, Skp has been shown to be in a dynamic 730 
equilibrium between folded monomer subunits and trimers32. All Skp concentrations referred 731 
to here are trimer equivalents.  For each experiment with a particular liposome batch, four 732 
samples were measured concurrently. A minimum of three replicates were globally fitted 733 
using IgorPro 6.0 (Wavemetrics, Oregon, USA) to extract rate constant(s), forcing the fits to 734 
share the same rate constant(s). Transients were fitted either to a single exponential function: 735 
 736 
ݕ = ܣ1 ∙ ݁ି௞ଵ௧ + 	ܿ 
or to a double exponential function: 737 
ݕ = ൫ܣ1 ∙ ݁ି௞ଵ௧൯ + (ܣ2 ∙ ݁ି௞ଶ௧) + 	ܿ 
Where k1 and k2 are rate constants, A1 and A2 are their associated amplitudes, and c is a 738 
constant. Transients were fitted to a double exponential function if a satisfactory fit was not 739 
obtained to a single exponential function as judged by inspection of residuals. Experiments 740 
were performed for each condition using three separate liposome batches, and reported 741 
errors are the standard deviation of rate constants between liposome batches. 742 
Fluorescence emission spectra 743 
Fluorescence emission spectra were acquired on the same instrument as the kinetic assays 744 
(above). Each spectrum was recorded from 305 nm to 400 nm in 1 nm increments, using an 745 
excitation wavelength of 295 nm. All spectra were acquired at 25 ºC and all samples 746 
contained 50 mM glycine-NaOH, pH 9.5, in a sample volume of 500 µL. OMPs from an 80 747 
µM stock in 8 M urea were diluted to a final concentration of 0.4 µM in the presence of a 2-748 
fold molar excess of Skp in 0.24 M urea, 8 M urea, or buffer alone in 0.24 M urea.  Folded 749 
samples were prepared by dilution of an 80 µM OMP stock to 0.4 µM in the presence of 1.28 750 
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mM DUPC liposomes (molar LPR 3200:1) in 0.24 M urea and incubated at 25 ºC for ~1.5 h 751 
prior to acquisition of the fluorescence emission spectra. 752 
 753 
Mass Spectrometry 754 
Skp:OMP complexes were prepared by rapid dilution of the denatured OMP (400 μM in 8 M 755 
urea, 50 mM glycine-NaOH, pH 9.5) to a final concentration of 5 μM into a solution of Skp (5 756 
μM in 50 mM glycine-NaOH, pH 9.5). The samples were then buffer exchanged into 200 mM 757 
ammonium acetate, pH 10 using Zeba spin desalting columns (Thermo Scientific, UK) 758 
immediately prior to MS analysis. nanoESI-IMS-MS spectra were acquired using a Synapt 759 
HDMS mass spectrometer (Waters Corporation, UK) using platinum/gold-plated borosilicate 760 
capillaries prepared in-house. Typical instrument parameters include: capillary voltage 1.2-761 
1.6 kV, cone voltage 40 V, trap collision voltage 6 V, transfer collision voltage 10 V, trap DC 762 
bias 20 V, backing pressure 4.5 mBar, IMS gas pressure 0.5 mBar, travelling wave height 7 763 
V, travelling wave velocity 250 ms-1. Data were processed using MassLynx v4.1, Driftscope 764 
2.5 (Waters Corporation, UK) and Massign55. CCSs were estimated by a calibration 765 
approach28,33,56 using arrival time data for ions with known CCSs (β-lactoglobulin A, avidin, 766 
concanavilin A and yeast alcohol dehydrogenase, all Sigma Aldrich, UK). Estimated modal 767 
CCSs are shown as mean ± standard deviation of three independent experiments. 768 
Theoretical CCSs for globular proteins with a given effective gas phase density were 769 
calculated according to published methods57.  770 
 771 
Chemical cross-linking and SDS-PAGE analysis. 772 
Samples for chemical cross-linking were prepared by rapid dilution of the urea denatured 773 
OMP into a Skp solution (in 20 mM HEPES pH 7.5, 150 mM NaCl) at 4 °C, so that the final 774 
concentrations of Skp and OMPs were 20 μM in a final concentration of 0.24 M urea. 775 
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Samples were mixed for 2 min and centrifuged (20 min, 13,000 g, 4 °C) to remove 776 
aggregated material. The supernatant was removed and bis(sulfosuccinimidyl)suberate (BS3) 777 
(Thermo Scientific, UK) was added at a 50-fold molar excess over the Skp concentration. 778 
Samples were incubated at room temperature for 30 min, before the addition of 250 mM 779 
glycine pH 9.5. Samples were analyzed by SDS-PAGE and the gels stained with Coomassie 780 
Blue (InstantBlue, Expedeon, UK), or the proteins transferred to a PVDF membrane and 781 
immunoblotted with an anti-His-HRP conjugated antibody (catalogue no. 15165, Thermo 782 
Scientific, UK). 783 
  784 
Gel bands were excised, cut into 1 mm3 pieces, destained with 30 % ethanol and washed 785 
with 50 % acetonitrile in 25 mM ammonium bicarbonate (10 min). The gel pieces were then 786 
dehydrated with acetonitrile (5 min), and the residual volatile solvent removed by 787 
evaporation. They were then rehydrated with a solution of trypsin (Promega, UK) (20 ng uL-1 788 
in 25 mM ammonium bicarbonate) and incubated at 37 °C for 18 hours. Peptides were 789 
recovered by incubating the gel pieces with 60 % acetonitrile/5 % formic acid (x 3), and the 790 
samples were then concentrated.  791 
 792 
Peptides were analysed by means of data-dependent LC-MS/MS on a nanoAcquity LC 793 
system interfaced to a Synapt G2-Si HDMS mass spectrometer (Waters Ltd., Wilmslow, 794 
Manchester, UK). Peptides (1 µL) were injected onto an Acquity M-Class C18, 75 µm x 150 795 
mm column (Waters Ltd., Wilmslow, Manchester, UK) and then separated by gradient 796 
elution of 1-50 % solvent B (0.1 % (v/v) formic acid in acetonitrile) in solvent A (0.1 % (v/v) 797 
formic acid in water) over 60 min at 0.3 µL min-1. Mass calibration was performed by a 798 
separate injection of aqueous sodium iodide at a concentration of 2 µg/µl. [Glu1]-799 
Fibrinopeptide B was infused as a lock mass calibrant. Data acquisition was achieved using 800 
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data dependent analysis with a one second MS scan over an m/z range of 350-2000 being 801 
followed by four 0.5 second MS/MS scans taken of the four most intense ions in the MS 802 
spectrum. Data processing was performed using PEAKS Studio 7 (Bioinformatics Solutions, 803 
Ontario, Canada). 804 
 805 
Modelling of Skp-OMP complexes 806 
All modelling was performed with the PyMOL Molecular Graphics System (v1.7rc1). To 807 
generate models of the Skp:OMP complexes, the missing residues in chains B and C of the 808 
Skp crystal structure (PDB: 1U2M10) were modelled from chain A. For the Skp:tOmpA/PagP 809 
model (Fig. 5a) the OMP was modelled as a sphere of radius 20 Å with its origin positioned 810 
at the geometric center between the α-carbon atoms of residue 50 of each Skp chain.  For 811 
the Skp:OMP model with expanded Skp subunits (Fig. 5b), each chain was positioned 812 
around a sphere of radius 25 Å representing the larger OMP. The flexible tips of each 813 
subunit (residues 51-101) were modelled hinged slightly inwards to wrap around the 814 
substrate. The side-by-side parallel and antiparallel 2:1 Skp:OMP models (Fig. 5c,d) were 815 
created by duplication of the Skp:tOmpA/PagP model (Fig. 5a) and appropriate rotation and 816 
translation. The interlocking trimer 2:1 Skp:OMP model (Fig. 5e) was generated by 817 
duplication of the Skp model with expanded subunits (Fig. 5b) and appropriate rotation and 818 
translation of the duplicated Skp. Theoretical CCS values were generated using the 819 
calibrated trajectory method implemented in the software IMPACT36. 820 
 821 
Molecular Dynamics Simulations 822 
Molecular dynamics (MD) simulations were prepared using the AmberTools 14 suite of 823 
programs, and performed using AMBER and the ff14SB forcefield58. To simulate apo-Skp in 824 
water, a Skp model was first generated from the Skp crystal structure (PDB: 1U2M10) with 825 
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the residues absent in chains B and C modelled from chain A. Following addition of 826 
hydrogen atoms using xleap, Skp was placed in a TIP3P water box with a 10.0 Å cutoff and 827 
the system neutralized with a total of 15 Cl- ions. The system was equilibrated by performing 828 
an initial energy minimization, followed by 80 ps of restrained MD during which the system 829 
was heated to 300 K with gradual releasing of restraints. This was followed by an 830 
unrestrained MD simulation of 100 ns. 831 
 832 
Simulations of the collapse of the extended chains of tOmpA and tBamA were carried out 833 
using a Generalized Born/Solvent Accessible surface area (GB/SA) implicit solvent 834 
model59,60. Use of an implicit solvent model speeds up exploration of conformational space 835 
by at least an order of magnitude due to the neglect of frictional forces from collisions with 836 
water molecules61, leading to rapid adoption of a collapsed configuration from the initially 837 
linear structure (Supplementary Fig. 7d, e, Supplementary Video 2).  The polypeptide 838 
starting structures were generated in xleap and, after initial energy minimization, were 839 
simulated for 3 ns. The starting models for the simulation of Skp-tOmpA and Skp2-tBamA in 840 
vacuo were created in PyMol by positioning OMPs, after simulated collapse, within the cavity 841 
of Skp trimer structures in an ‘open’ conformation taken from the explicit solvent apo-Skp 842 
simulation. All simulations except apo-Skp in explicit water were performed in triplicate. Each 843 
in vacuo simulation of Skp-tOmpA and 2:1 Skp:tBamA was performed using a starting OMP 844 
structure from a different simulation. In vacuo simulations of apo-Skp were performed using 845 
three different starting structures selected from the simulation of apo-Skp in explicit water. 846 
For all in vacuo simulations the system was equilibrated by performing an initial energy 847 
minimization, followed by eight steps of restrained MD during which the system was heated 848 
to 300 K with gradual releasing of restraints.  This was followed by an unrestrained MD 849 
simulation of 100 ns. 850 
 851 
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To simulate the 1:1 Skp:tOmpA and 2:1 Skp:tBamA complexes in solution, starting models 852 
were generated as detailed above for the in vacuo simulations. The Skp:OMP complexes 853 
were placed in a TIP3P water box with a 10.0 Å cutoff and the system neutralized with a total 854 
of 10 Cl- ions (1:1 Skp:tOmpA) or 12 Cl- ions (2:1 Skp:tBamA). The systems were 855 
equilibrated by performing an initial energy minimization, followed by 80 ps of restrained MD 856 
during which the system was heated to 300 K with gradual releasing of restraints. This was 857 
followed by an unrestrained MD simulation of 100 ns. For each complex simulations were 858 
repeated in triplicate. 859 
 860 
For comparison with IMS-MS data, theoretical collision cross-sections (CCSs) of final 861 
structures at the end of simulations were calculated using the trajectory method and the 862 
software IMPACT36. CCS values for all structures following in vacuo simulations were 863 
obtained after 100 ns of unrestrained simulation. CCS values for tOmpA and tBamA in 864 
implicit solvent were obtained after 3 ns of unrestrained simulation. The integration time-step 865 
was 2 fs and atomic positions were saved every 500 steps (1 ps). The software VMD was 866 
used to compute backbone root mean square deviation (RMSD) and to render videos of the 867 
simulations. Analysis of radius of gyration changes over trajectories were carried out with 868 
ptraj. 869 
  870 
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